GLP1R and depressive symptom measurement: In the hippocampus, in the model of the co-occurrence of depression and obesity, the decreased in GLP-1 receptor suggests that neurodegenerative changes may be more severe in the case of coexistence of the two diseases compared to those observed in obesity or in depression.